1195977-16-2

Upstream product

• 447433-47-8 2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4(3H)-one 
• 54802-12-9 2-(2-cyanophenoxy)acetamide 
• 611-20-1 salicylonitrile 
• 447433-47-8 C₁₇H₉F₃N₂O₂ 
• 898373-46-1 3-(4-(trifluoromethyl)benzamido)benzofuran-2-carboxamide 
• 329-15-7 4-trifluoromethyl-phenyl acetyl chloride 
• 54802-10-7 3-aminobenzofuran-2-carboxamide 

Downstream Products

• 1275620-42-2 {4-cyclopropanesulfonylaminocarbonyl-2,15-dioxo-18-[2-(4-trifluoromethyl-phenyl)-benzo[4,5]furo[3,2-d]pyrimidin-4-yloxy]-3,16-diaza-tricyclo[14.3.0.0(4,6)]nonadec-7-en-14-yl}-carbamic acid cyclopentyl ester 
• 1195977-18-4 C₂₃H₁₈F₃N₃O₄ 
• 1195977-22-0 C₄₆H₅₁F₃N₆O₉S 
• 1275620-40-0 C₃₈H₄₁F₃N₄O₇ 
• 1275620-41-1 C₃₇H₃₉F₃N₄O₇ 
• 1275617-56-5 {4-cyclopropanesulfonylaminocarbonyl-2,15-dioxo-18-[2-(4-trifluoromethyl-phenyl)-benzo[4,5]furo[3,2-d]pyrimidin-4-yloxy]-3,16-diaza-tricyclo[14.3.0.0(4,6)]nonadec-14-yl}-carbamic acid cyclopentyl ester 
• 1315325-52-0 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclo-propylsulfonyl)-6-(4,5-dimethylthiazol-2-ylamino)-5,16-dioxo-2-(2-(4-(trifluoromethyl-)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-96-5 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-5,16-dioxo-6-thioureido-2-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-95-4 (2R,6S,13aS,14aR,16aS,Z)-6-amino-N-(cyclopropylsulfonyl)-5,16-dioxo-2-(2-(4-(trifluoromethyl)phenyl)-benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrol-e[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide hydrochloride 
• 1195976-53-4 C₄₃H₄₇F₃N₆O₉S 
• 1315324-53-8 methyl 2-((2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl-carbamoyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy-)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)thiazole-4-carboxylate 
• 1315326-73-8 (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315326-72-7 C₄₂H₄₇F₃N₆O₉S 
• 1315326-71-6 (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 

Relevant academic research and scientific papers

HCV PROTEASE INHIBITORS

This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection.

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds shown in the specification. These compounds can be used to treat hepatitis C virus infection.